Page 6 - Cell Reports News Today

Our immune system offers essential protection to our body, summoning chemical agents and cellular assassins to sites of damage in skirmishes we experience as inflammation.

Researchers confirm that the established pre-mRNA splicing mechanism that appears in textbooks cannot work in a subset of human short introns: A novel SAP30BP�

A research team has grown tumour organoids in the lab, in order to predict what drugs will work for bowel cancer patients before they begin treatment.

In modern open work environments, acoustic sensory overload can be a hindrance to productivity, satisfaction, and wellbeing.

A new study has identified 348,000 square kilometers (134,364 square miles) of shallow coral reefs, up to 30 meters (98 feet) deep.

In the treatment of aggressive lymphomas and blood cancer (leukaemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used.

Researchers at Osaka University uncover the mechanism by which cysteine activates a crucial regulator of cell growth in yeast. Amino acids serve as life's fundamental components. They are sourced from our diet, and our bodies utilize them to create proteins. These proteins are crucial for growth, d

<p style="text-align:justify"><em>Scientists from University Hospital Cologne have developed a procedure in the laboratory that effectively fights the affected cells in lymphoma cancer, but does not damage healthy immune cells, which is often the case with comparable therapies / publication in ‘Cell Reports Medicine’</em></p>

CAR T cell therapy, using genetically engineered immune cells, shows promise in treating lymphomas and leukemia.

CAR T cell therapy, using genetically engineered immune cells, shows promise in treating lymphomas and leukemia.